Advances in preclinical and clinical studies of oncolytic virus combination therapy
Oncolytic viruses represent a distinct class of viruses that selectively infect and destroy tumor cells while sparing normal cells. Despite their potential, oncolytic viruses encounter several challenges as standalone therapies. Consequently, the combination of oncolytic viruses with other therapeut...
Saved in:
Main Authors: | Wenlong Du, Jintong Na, Liping Zhong, Pumin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1545542/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving systemic delivery of oncolytic virus by cellular carriers
by: Ziyi Peng, et al.
Published: (2024-12-01) -
Advanced progress in the genetic modification of the oncolytic HSV-1 virus
by: Mi Zhou, et al.
Published: (2025-01-01) -
The impact of innate immune response on the efficacy of oncolytic viruses
by: Kirill N. Trachuk, et al.
Published: (2024-12-01) -
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
by: MENG Zihe, et al.
Published: (2025-01-01) -
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
by: Merve Kulbay, et al.
Published: (2025-01-01)